Experience with ustekinumab in reservoir Crohn's disease
Rev Esp Enferm Dig. 2021 Nov 25. doi: 10.17235/reed.2021.8457/2021. Online ahead of print.ABSTRACTCrohn's disease of the reservoir is a pathology of difficult diagnosis and complex approach due to the scarce documented evidence on it. Recently, studies have been published on the treatment strategies available for this entity. Based on the above, we have analyzed the experience of our center in the treatment of reservoir Crohn's disease with one of the new biologic agents, ustekinumab.PMID:34818897 | DOI:10.17235/reed.2021.8457/2021
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Authors: Mar ía Martínez Burgos Isabela Angulo McGrath V íctor Amo Trillo Ra úl Olmedo Martín Patricia Romero Caro Jos é Mostazo Torres Miguel Jim énez Pérez Source Type: research
More News: Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Pathology | Stelara | Study